226 related articles for article (PubMed ID: 25018831)
1. Possible macrophage activation syndrome following initiation of adalimumab in a patient with adult-onset Still's disease.
Souabni L; Dridi L; Ben Abdelghani K; Kassab S; Chekili S; Laater A; Zakraoui L
Pan Afr Med J; 2014; 17():94. PubMed ID: 25018831
[TBL] [Abstract][Full Text] [Related]
2. Reintroduction of tocilizumab elicited macrophage activation syndrome in a patient with adult-onset Still's disease with a previous successful tocilizumab treatment.
Naniwa T; Uehara K; Yamabe T; Ohmura SI
Mod Rheumatol Case Rep; 2021 Jul; 5(2):360-364. PubMed ID: 32883165
[TBL] [Abstract][Full Text] [Related]
3. Macrophage activation syndrome in patients with adult-onset Still's disease under tocilizumab treatment: A single-center observational study.
Yamabe T; Ohmura SI; Uehara K; Naniwa T
Mod Rheumatol; 2022 Jan; 32(1):169-176. PubMed ID: 33719871
[TBL] [Abstract][Full Text] [Related]
4. Reactive macrophage activation syndrome possibly triggered by canakinumab in a patient with adult-onset Still's disease.
Banse C; Vittecoq O; Benhamou Y; Gauthier-Prieur M; Lequerré T; Lévesque H
Joint Bone Spine; 2013 Dec; 80(6):653-5. PubMed ID: 23751410
[TBL] [Abstract][Full Text] [Related]
5. An unusual case of adult-onset still's disease complicated with anti-complement factor H antibodies associated atypical haemolytic uraemic syndrome.
Fung WW; Chao AC; Pang WF; Wong RS; Chow KM; Szeto CC
BMC Nephrol; 2024 May; 25(1):164. PubMed ID: 38745129
[TBL] [Abstract][Full Text] [Related]
6. Rescued from desperation: adult-onset Still's disease with life-threatening interstitial lung disease and macrophage activation : Successful treatment by Tocilizumab.
Zhang G; Liu W; Zhang X; Liu L
Z Rheumatol; 2022 May; 81(4):335-338. PubMed ID: 34378080
[TBL] [Abstract][Full Text] [Related]
7. Adult-onset Still's disease complicated with hemophagocytic syndrome.
Yeh HM; Liu MF; Chang KK; Liu SM; Chen CH
J Formos Med Assoc; 2010 Jan; 109(1):85-8. PubMed ID: 20123591
[TBL] [Abstract][Full Text] [Related]
8. Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome.
Kobayashi M; Takahashi Y; Yamashita H; Kaneko H; Mimori A
Mod Rheumatol; 2011 Feb; 21(1):92-6. PubMed ID: 20737186
[TBL] [Abstract][Full Text] [Related]
9. Baseline clinical features predicting macrophage activation syndrome in patients with systemic adult-onset Still's disease receiving interleukin-6 inhibitor treatment.
Naniwa T; Yamabe T; Ohmura SI; Uehara K; Tamechika SY; Maeda S; Isogai S; Wada J
Int J Rheum Dis; 2022 Sep; 25(9):1003-1012. PubMed ID: 35719030
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 and adult-onset Still's disease as part of hyperferritinemic syndromes.
Kawasaki T; Ooka S; Mizushima M; Nakamura Y; Ikeda H; Sakurada T; Suzuki S; Yamazaki K; Goto Y; Sakurai K; Yukitaka Y; Kiyokawa T; Tonooka K; Kunishima H; Kawahata K
Mod Rheumatol Case Rep; 2022 Jan; 6(1):101-105. PubMed ID: 34592766
[TBL] [Abstract][Full Text] [Related]
11. A Recurrent Case of Adult-onset Still's Disease with Concurrent Acalculous Cholecystitis and Macrophage Activation Syndrome/Hemophagocytic Lymphohistiocytosis Successfully Treated with Combination Immunosuppressive Therapy.
Arai Y; Ishikawa Y; Abe K; Kato Y; Abe D; Fujiwara M; Kita Y
Intern Med; 2021 Jun; 60(12):1955-1961. PubMed ID: 33518559
[TBL] [Abstract][Full Text] [Related]
12. Two cases of adult-onset Still's disease treated with tocilizumab that achieved tocilizumab-free remission.
Kobayashi D; Ito S; Murasawa A; Narita I; Nakazono K
Intern Med; 2015; 54(20):2675-9. PubMed ID: 26466710
[TBL] [Abstract][Full Text] [Related]
13. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
Lenert A; Yao Q
Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
[TBL] [Abstract][Full Text] [Related]
14. Successful use of short-term add-on tocilizumab for refractory adult-onset still's disease with macrophage activation syndrome despite treatment with high-dose glucocorticoids, cyclosporine, and etoposide.
Ohmura SI; Uehara K; Yamabe T; Tamechika S; Maeda S; Naniwa T
Mod Rheumatol Case Rep; 2020 Jul; 4(2):202-207. PubMed ID: 33086994
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive review on adult onset Still's disease.
Giacomelli R; Ruscitti P; Shoenfeld Y
J Autoimmun; 2018 Sep; 93():24-36. PubMed ID: 30077425
[TBL] [Abstract][Full Text] [Related]
16. Intravenous anakinra to curb cytokine storm in adult-onset Still's disease and in macrophage activation syndrome: A case series.
Bindoli S; Galozzi P; Doria A; Sfriso P
Joint Bone Spine; 2023 Mar; 90(2):105524. PubMed ID: 36623798
[TBL] [Abstract][Full Text] [Related]
17. Adult-onset Still's disease with disseminated intravascular coagulation and hemophagocytic syndrome: a case report.
Mimura T; Shimodaira M; Kibata M; Tsukadaira A; Shirahata K
BMC Res Notes; 2014 Dec; 7():940. PubMed ID: 25532568
[TBL] [Abstract][Full Text] [Related]
18. Successful tocilizumab therapy in seven patients with refractory adult-onset Still's disease.
Bannai E; Yamashita H; Kaneko S; Ueda Y; Ozaki T; Tsuchiya H; Takahashi Y; Kaneko H; Kano T; Mimori A
Mod Rheumatol; 2016; 26(2):297-301. PubMed ID: 24697199
[TBL] [Abstract][Full Text] [Related]
19. Adult-onset Still's disease with neurological involvement: a single-centre report.
Zhao M; Wu D; Shen M
Rheumatology (Oxford); 2021 Sep; 60(9):4152-4157. PubMed ID: 33369675
[TBL] [Abstract][Full Text] [Related]
20. Fulminant elderly adult-onset Still disease effectively treated with tocilizumab and methotrexate: A case report.
Horiuchi Y; Hashimoto K; Horikoshi H; Sano A; Kawamura Y; Fujita N; Kimata M; Ono Y; Obuchi Y; Makino A; Kaneko M; Kimura F; Itoh K; Tanaka Y
Medicine (Baltimore); 2022 Jul; 101(28):e29354. PubMed ID: 35839054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
